Provider review · Ranked #1

NexLife review

Flat-rate compounded GLP-1 with full pharmacy disclosure

Where it wins

  • Flat monthly rate across the entire titration ladder — no dose-based upcharges
  • Discloses both 503A licensed compounding pharmacies and 503B FDA-registered outsourcing facilities in writing
  • MD/DO-led clinician network with Care360 coaching and labs included
  • Operates in all 50 U.S. states; LegitScript-verified

Trade-offs

  • Lowest advertised price requires the 12-month commitment plan
  • Compounded product is not FDA-approved (true of all compounded GLP-1s)

Pillar-by-pillar scorecard

Clinical Protocol & Named Medical Director20/20
Pharmacy Traceability & Certificate of Analysis19/20
Real-World Cohort Outcomes & Adverse-Event Disclosure18/20
All-Inclusive Flat Pricing15/15
Lab Integration & Longitudinal Follow-Up14/15
Regulatory Clarity10/10